Cytokinetics. Every tracked FinTwit mention of $CYTK, newest first. 19 mentions since the first on Aug 30, 2025. See the price chart.
May 2026 · 4 mentions
May 5
Adam Feuerstein ✡️ — $CYTK safety
On the safety side, 10% of patients treated with Myqorzo saw their left ventricle ejection fraction, a measure of the heart’s squeezing function, dip below the norma…↗
May 5
Adam Feuerstein ✡️ — Here are the ACACIA co-primary endpoint data in chart form. $CYTK https://t.co/4Wx89joZdG↗
May 5
Adam Feuerstein ✡️ — $CYTK Here we go! Myqorzo ACACIA study results in nHCM --> BOTH co-primary endpoints hit with statistical significance.
There may be debate about magnitude of improvements for My…↗
Adam Feuerstein ✡️ — $CYTK Blum announces Myqorzo WAC price of $108,400 -- "parity slight plus" relative to $BMY Camzyos #JPM26↗
Jan 12
Adam Feuerstein ✡️ — $CYTK CEO Robert Blum starts his #JPM26 presentation:
"After over 20 years presenting at this conference we are now a company that is commercial."
The audience clapped!
Possi…↗
December 2025 · 6 mentions
Dec 19
Adam Feuerstein ✡️ — And with the $CYTK story done, I am finished for 2025.
This year has been a wild ride. Never boring. I will be back on Mon. Jan. 4, unless something spectacularly newsy needs my…↗
Dec 19
Adam Feuerstein ✡️ — $CYTK Cytokinetics heart drug wins FDA approval, the biotech’s first https://t.co/BC04Z4AlJM↗
Dec 19
Adam Feuerstein ✡️ — Here are the Myqorzo and Camzyos black box warnings side by side
$CYTK $BMY https://t.co/XnO8QG0QnU↗
Adam Feuerstein ✡️ — @Biohazard3737 I put together a Q4 list, fairly active heading into end of year, which is nice. Will post it later in the week.
$INSM $NKTR $GPCR $CYTK among others↗
Adam Feuerstein ✡️ — Robert Blum should call Sarah Boyce tonight.
"Sarah, this is Robert. Hey, let me tell you how this goes, from experience...."
$CYTK $RNA↗
Sep 9
Adam Feuerstein ✡️ — $NVS speculation tied to acquisitions of $CYTK and $RNA
Then, $NVS buys $TRML.
Ok!
August 2025 · 2 mentions
Aug 30
Adam Feuerstein ✡️ — @Biohazard3737 When I talked to $CYTK this week, they told me insurers still likely to require beta bets blockers first (generic, cheap) but MAPLE data will persuade doctors to swi…↗
Aug 30
Adam Feuerstein ✡️ — Cytokinetics $CYTK drug yielded benefits over common therapy in patients with heart condition, study shows https://t.co/pg3egDxRwq $BMY↗
Adam Feuerstein ✡️ — $CYTK aficamten (Myqorzo) approved in China today. A positive CHMP recommendation last week. Waiting on the FDA decision, hopefully before its Dec. 26 PDUFA.↗